The purpose of the clinical trial is to demonstrate how effective Embrace and Alert App are in detecting for possible convulsive seizures and alerting caregivers.
It’s necessary to test on a large number of people to ensure that any benefit derived from the Embrace is not random. The clinical trial is overseen by a review board which protects the participants by monitoring the trial.
Our goal is to produce objective evidence that our detection algorithm and alerting system facilitates first-response time. We also hope to further the understanding of epilepsy, and obtain useful data for epilepsy management.
If you are interested in participating, please visit How can I join the clinical trial?
By participating in the clinical trial you are helping advance scientific progress in the Epilepsy research space. You are also contributing to an improved user experience with Embrace, and helping reduce the false alarm rate.